|
High $1.20 |
Low $1.17 |
Trades 19 |
Turnover $42,881 |
Volume 36,527 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $131,996,888 (664th) |
Close (30-Jun) $1.17 |
Volume (30-Jun) 36,527 |
Shortsold (27-Jul) 18 (0.00%) (681st) |
|
52w High $1.96 |
52w Low $1.39 |
P/E - |
EPS -0.09 |
Notice of Annual General Meeting/Proxy Form
EMV released this announcement to the ASX on 26 October 2021, 13:32. The announcement is not marked as price sensitive, and is 24 page(s) in length and 597.95kb in size.
You can view all announcements from EMV and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMV was 0.005% short sold according to ASIC data. It was ranked the 625th most shorted stock on the ASX. It remains ranked 681st as of the latest reported data (27 July 2026).
| Other Recent Announcements from EMV | |
|---|---|
| Recruitment at Royal Melbourne Hospital Commences | 29 June 2023, 8:20 |
| $1.75M Manufacturing Grant Payment Received | 13 June 2023, 9:05 |
| Leadership Transition | 31 May 2023, 9:00 |
| Notice of Annual General Meeting/Proxy Form | 26 October 2021, 13:32 |
| Investor Presentation - Morgans Scone Conference | 21 October 2021, 9:08 |
| Brain Scanner Published in Peer-Reviewed Medical Journal | 18 October 2021, 9:42 |
| FDA Breakthrough Device Application Update | 6 October 2021, 8:22 |
If you were already registered, log in here.